Inhibitors of CCR9 activity

Details for Australian Patent Application No. 2006328903 (hide)

Owner Novartis AG

Inventors Winiski, Anthony; Carballido Herrera, Jose M.; Jaksche, Herbert; Lehr, Philipp; Werner, Gudrun

Agent Davies Collison Cave

Pub. Number AU-A-2006328903

PCT Pub. Number WO2007/071443

Priority 0526252.2 22.12.05 GB

Filing date 22 December 2006

Wipo publication date 28 June 2007

International Classifications

C07C 311/21 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

A61K 31/18 (2006.01) - Sulfonamides

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

C07C 311/29 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

Event Publications

26 June 2008 PCT application entered the National Phase

  PCT publication WO2007/071443 Priority application(s): WO2007/071443

1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006328905-Polypropylene composition comprising a propylene copolymer component

2006328902-Inhibitors of CCR9 activity